Joseph Biederman News - The New York Times: "He is in the middle of two controversies: one involves the use of antipsychotic drugs in children, and the other relates to conflicts of interest in medicine.
An inquiry by Senator Charles E. Grassley, Republican of Iowa, revealed last year that Dr. Biederman earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but failed to report all but about $200,000 of this income to university officials, according to information given Congressional investigators."
Thursday, September 16
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment